Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000897069-25-000101
Filing Date
2025-01-13
Accepted
2025-01-13 15:33:33
Documents
1
Effectiveness Date
2025-01-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8197
  Complete submission text file 0000897069-25-000101.txt   9389
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Filer) CIK: 0001797409 (see all company filings)

EIN.: 842985609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-500632 | Film No.: 25526223